Promo !

TB-500 500 mcg – 40 capsules

Le prix initial était : $85.00.Le prix actuel est : $80.00.

Catégorie : Étiquette :

TB-500 oral research capsules. TB-500 is a synthetic peptide derivative based on thymosin β4 (Tβ4) — a 43-amino-acid actin-sequestering peptide expressed at high concentration in virtually every mammalian tissue and one of the most extensively characterized regenerative peptides in modern preclinical research. The proximal active fragment, residues 17-23 (Ac-LKKTETQ-OH), retains the principal actin-binding and angiogenic activity of the parent molecule in a far smaller, more synthetically tractable peptide. Across two decades of preclinical work, TB-500 / Tβ4 has been characterized in models of cardiac, dermal, corneal, neural, hepatic and musculoskeletal injury, with progression to Phase II/III clinical trials for dermal repair (RGN-137), dry eye and neurotrophic keratopathy (RGN-259, Phase 3) and wound healing.

 

RESEARCH USE ONLY  ·  Not for human or veterinary use. For laboratory and collector purposes only.

 

Purity
≥ 98 % (HPLC) — third-party tested, CoA on file
Form
Research capsules
Content
500 mcg TB-500 per capsule, 40 capsules per bottle (20 mg total)
Total
40 capsules per bottle
Packaging
Sealed bottle with tamper-evident closure
Storage
2–8 °C preferred, dry, protected from light
Parent peptide
Thymosin β4 (Tβ4); 43 amino acids; MW ≈ 4963.4 g·mol⁻¹
Active fragment
Ac-LKKTETQ-OH (residues 17-23 of Tβ4); MW ≈ 889.0 g·mol⁻¹
Sequence (parent)
Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH
CAS number
77591-33-4 (Thymosin β4)
Synonyms
Tβ4; TMSB4X; thymosin beta-4

 

Research Overview

Thymosin β4 (Tβ4) is the most abundant member of the β-thymosin family in mammalian cells, where its principal known function is sequestration of monomeric G-actin to maintain a polymerization-ready intracellular pool [1]. Beyond this canonical role, Tβ4 has emerged over two decades as a remarkably broad-spectrum tissue-repair signaling peptide: in well-characterized models, it accelerates epicardial-progenitor activation and infarct repair after myocardial injury; promotes dermal wound closure and reduces scarring; supports corneal epithelial healing; modulates angiogenesis through downstream VEGF signaling; and exhibits neuroprotective activity in stroke and traumatic brain injury models [1,2]. The active fragment Ac-LKKTETQ — corresponding to the actin-binding domain — replicates the principal repair activity in a chemically simpler, more synthetically tractable molecule [2]. Tβ4 has progressed through multiple Phase II clinical trials: RGN-137 for epidermolysis bullosa, RGN-259 for dry eye disease and neurotrophic keratopathy (Phase 3), and earlier programs for chronic wound healing [3].

 

Primary Research Areas

  • Tissue repair and wound healing — robust evidence of accelerated dermal, corneal and epithelial closure across multiple injury models, with downstream signaling involving Akt, MAPK and integrin pathways [1,2].
  • Cardiac repair and post-MI regeneration — Tβ4 reactivates epicardial progenitor cells in the adult heart — a developmental population thought lost in adulthood — providing a unique mechanistic angle for post-infarct repair research [1].
  • Angiogenesis and vascular biology — modulates endothelial cell migration, capillary tube formation and VEGF-mediated neovascularization in ex vivo and in vivo models [2].
  • Ophthalmology research — the corneal application has progressed furthest clinically; RGN-259 has been evaluated in multiple Phase II trials for dry eye and neurotrophic keratopathy [3].
  • Neuroprotection and CNS repair — characterized in models of stroke, traumatic brain injury and multiple sclerosis with reproducible neuroprotective signals [2].

 

References

  1. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37–51.
  2. Crockford D, Turjman N, Allan C, Angel J. Thymosin β4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010;1194:179–189.
  3. Sosne G, Kim C, Kleinman HK. Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye. Expert Opin Biol Ther. 2015;15(suppl 1):S155–S161.
TB-500 is a lab-synthesized peptide fragment (amino acids 17–23) that mimics the active region of Thymosin Beta-4 (Tβ4), a naturally occurring protein found in human and animal tissues. [1, 2]

Key Functions and Mechanisms

  • Actin Regulation: It binds to and regulates actin (a protein needed for cell structure and movement), which helps cells migrate toward damaged tissue. [1, 2]

  • Angiogenesis: It supports the formation of new blood vessels, improving blood flow and nutrient delivery to healing areas. [1, 2]

  • Inflammation Modulation: It helps dampen inflammatory signals and reduce scar tissue formation in soft tissues and muscles. [1, 2]

  • Systemic Reach: Unlike localized treatments, TB-500 is distributed systemically throughout the body rather than acting on a single spot. [1, 2]

Common Contexts and Popularity

  • The “Wolverine Stack”: Enthusiasts and athletes frequently pair TB-500 with BPC-157 (another experimental healing peptide) in a combination commonly referred to as the “Wolverine Stack” to support recovery from training or soft-tissue strains. [1, 2]

  • Anecdotal vs. Clinical Evidence: While widely discussed in fitness communities for speeding up muscle, tendon, and joint recovery, robust human clinical trials are lacking. [1, 2]

Safety and Regulation

  • Not FDA Approved: TB-500 is not approved by the U.S. Food and Drug Administration (FDA) for human medical use. [1, 2]

  • Status in Sports: It is banned in competitive human sports by the World Anti-Doping Agency (WADA) and is restricted or classified as a prescription-only substance in some regions (such as Australia and New Zealand), or tracked in equine racing. [1]

  • Unknown Safety Profile: Long-term human safety, proper dosing guidelines, and potential side effects (including theoretical links to cell growth or tumor progression noted in research literature) are not well-established. [1, 2]

Why Limitless Biochem Shop?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “TB-500 500 mcg – 40 capsules”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list